Novo Nordisk A/S (NVO)

$59.84 0.53 (0.89%)

18:30 EDT NVO Stock Quote Delayed 20 Minutes

Volume:

Previous Close $59.84

Market Cap 144.77B

PE Ratio 3.80

EPS 15.73

Volume (Avg. Vol.) 1.98M

Day's Range 59.25 - 60.39

52-Week Range 46.47 - 64.82

Dividend & Yield 0.91 (1.52%)

NVO Stock Predictions, Articles, and Novo Nordisk A/S News

From InvestorPlace
From the Web

10 Biotech Stocks With Game-Changing Dates in Q3

By James Brumley, InvestorPlace Feature Writer Jul 3, 2017

If you're looking to speculate in the inherent volatility of biotech stocks, here are ten impending events that could cause those fireworks.

5 Reasons Why VIVUS, Inc. (VVUS) Stock Should Be in Your Portfolio

By Zacks Investment Research May 25, 2017

VIVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies. Here's why VVUS stock is a must

Global Blood Therapeutics Inc (GBT) Stock Soars on Takeover Talk

By Karl Utermohlen, InvestorPlace Writer Mar 8, 2017

Global Blood Therapeutics (GBT) stock is rising as the company is being targeted for a takeover by another pharma corporation. Here's what's happenig

9 Top Pharmaceutical Stocks to Buy for the Dividends

By James Brumley, InvestorPlace Feature Writer Feb 13, 2017

Fans of dividends don't have to completely abandon all hope for growth too -- these top pharmaceutical stocks offer the best of both worlds.

3 European Stocks to Buy for Big-Time Dividends

By Aaron Levitt, InvestorPlace Contributor Dec 8, 2016

Don't overlook European stocks when it comes to dividends. Companies like Diageo (DEO), Novo Nordisk (NVO) and Eni (E) are stellar.

3 Big Pharma Stocks Under Pressure From Washington

By Profit Scanner Nov 4, 2016

We cover the technical condition of three Big Pharma stocks, with the help of Profit Scanner, to determine where their prices may be headed.

Compare Brokers

7 Healthcare Stocks That Are Investor Poison

By Louis Navellier, Editor, Growth Investor Oct 21, 2016

You can't blindly buy stocks in healthcare because there are some that have some serious problems.

5 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Oct 7, 2016

The ratings of 5 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

14 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Sep 16, 2016

The overall ratings of 14 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

12 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Aug 19, 2016

This week, the overall grades of 12 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

9 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Aug 12, 2016

This week, 9 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").